Gemcitabine + vinorelbine (GV) yields better survival than vinorelbine (V) alone in elderly non-small cell lung cancer (NSCLC) patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

G. Frasci, Vito Lorusso, N. Panza, P. Comella, E Micillo, Nunzio Iannelli, Gianfranco Filippelli, Dario Muci, Francovito Piantedosi, M Belli,

Lung Cancer · 2000 · 11 citations · 0 references

Concepts